Koers Shanghai Labway Clinical Laboratory Co., Ltd
Aandelen
301060
CNE100004RG8
Gezondheidszorgvoorzieningen & -diensten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,1 CNY | +0,78% | -5,99% | -31,53% |
Omzet 2021 | 1,78 mld. 245 mln. 229 mln. | Omzet 2022 | 4,2 mld. 580 mln. 541 mln. | Marktkapitalisatie | 7,85 mld. 1,08 mld. 1,01 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 204 mln. 28,15 mln. 26,31 mln. | Nettowinst (verlies) 2022 | 617 mln. 85,15 mln. 79,56 mln. | EV/omzet 2021 | 7,42 x |
Nettoliquiditeiten 2021 | 707 mln. 97,59 mln. 91,19 mln. | Nettoliquiditeiten 2022 | 421 mln. 58,13 mln. 54,32 mln. | EV/omzet 2022 | 1,77 x |
K/w-verhouding 2021 |
60,1
x | K/w-verhouding 2022 |
12,7
x | Werknemers | 1.878 |
Dividendrendement 2021 |
0,86% | Dividendrendement 2022 |
1,53% | Vrij verhandelbaar | 32,29% |
1 dag | +0,78% | ||
1 week | -5,99% | ||
Lopende maand | -23,85% | ||
1 maand | -31,32% | ||
3 maanden | -15,74% | ||
6 maanden | -30,16% | ||
Lopend jaar | -31,53% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wei Xiong Zeng
CEO | Chief Executive Officer | 56 | 20-08-15 |
Xi Gu Wang
DFI | Director of Finance/CFO | 54 | 22-07-22 |
Zhi Sen Mao
BRD | Director/Board Member | 64 | 17-12-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lei Wang
BRD | Director/Board Member | 42 | 17-12-21 |
Wei Xiong Zeng
CEO | Chief Executive Officer | 56 | 20-08-15 |
Hui Juan Jing
BRD | Director/Board Member | 53 | 20-08-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.07% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 9,1 | +0,78% | 4 534 926 |
19-04-24 | 9,03 | -0,44% | 4 711 217 |
18-04-24 | 9,07 | -3,30% | 5 825 050 |
17-04-24 | 9,38 | +8,82% | 7 713 508 |
16-04-24 | 8,62 | -10,95% | 8 639 496 |
slotkoers Shenzhen S.E., 22 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-31,53% | 503 mln. | |
-16,30% | 8,18 mld. | |
+39,57% | 3,51 mld. | |
-28,32% | 2,9 mld. | |
-7,53% | 2,47 mld. | |
-12,74% | 2,25 mld. | |
-18,63% | 1,47 mld. | |
-39,86% | 1,22 mld. | |
+6,64% | 1,1 mld. | |
-13,80% | 1,09 mld. |